Apollo Endosurgery Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Apollo Endosurgery Inc with three other
companies in this sector in the United States:
sales of $65.87 million
of which 53%
Momenta Pharmaceuticals, Inc.
of which 100%
was Drug Products), and
Xtant Medical Holdings Inc
of which 68%
Apollo Endosurgery Inc reported sales of $60.85 million
December of 2018.
decrease of 5.4%
versus 2017, when the company's sales were $64.31 million.